Dr. Rasha Al-Lamee and Dr. C. Michael Gibson Discuss: AHA 2022 ACCess Points Daily Wrap-Up – November 7, 2022 November 7, 2022 Disclosures: TBD
Dr. Marc Bonaca and Dr. C. Michael Gibson Discuss: Aortic Disease Guidelines November 7, 2022 Disclosures: TBD
Dr. Payal Kohli and Dr. C. Michael Gibson Discuss: AHA 2022 ACCess Points Daily Wrap-Up – November 6, 2022 November 7, 2022 Disclosures: TBD
Dr. Payal Kohli and Dr. C. Michael Gibson Discuss: Deep Dive on Prevention Trials at AHA 2022 November 7, 2022 Disclosures: TBD
Dr. Julia Grapsa and Dr. C. Michael Gibson Discuss: AHA 2022 ACCess Points Daily Wrap-Up – November 5, 2022 November 7, 2022 Disclosures: TBD
Dr. Cian McCarthy and Dr. C. Michael Gibson Discuss: Implementation of High-Sensitivity Cardiac Troponin Assays in the United States November 7, 2022 Disclosures: TBD
Dr. Steve Nissen, Dr. Luke Laffin, and Dr. C. Michael Gibson Discuss: Comparative Effects of Low-Dose Rosuvastatin, Placebo and Dietary Supplements on Lipids and Inflammatory Biomarkers November 7, 2022 Disclosures: TBD
Dr. Michael Mack and Dr. C. Michael Gibson discuss the STAR-T/D trials in which a column of microbeads attached to the bypass pump are used to remove ticagrelor, rivaroxaban, and apixaban May 25, 2022 Disclosures: TBA
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Secondary Analysis Of The CANTOS Trial: Differential Impact Of Residual Inflammatory Risk And Residual Cholesterol Risk Among Atherosclerosis Patients With And Without Chronic Kidney Disease April 4, 2022 Disclosures: TBA
Dr. Felix Mahfoud and Dr. C. Michael Gibson Discuss: 3-year Efficacy Outcomes From The Spyral Htn-on Med Pilot Study: Long Term Effect Of Renal Denervation On Blood Pressure Reduction In Patients On Antihypertension Medications April 4, 2022 Disclosures: TBA
